| Primary information |
|---|
| ID | antitb_1478, |
| Name | 25681127 |
| N-Terminal modification | Lariatin A |
| C-Terminal Modification | GSQLVYRWVGHSNVIKGP |
| Length | Alpha carbon of glutamine form amide bond with first glycine and gamma carbon of glutamine involved in side chain formation |
| Chirality | Cyclic |
| Nature | 18 |
| Source | D |
| Origin | Cationic |
| Species | Natural |
| Strain | Derived from Rhodococcusjostii K01â€B0171 |
| Inhibition Concentration | Mycobacterium tuberculosis |
| In Vitro/ In vivo | Mycobacterium tuberculosis Rv |
| Cell Line | MIC = 0.39 mg/L |
| Inhibition Concentration | in vitro |
| Sequence | 2015 |
| Cytotoxicity | NA |
| In vivo Model | NA |
| Lethal Dose | NA |
| Immune Responce | NA |
| Mechanism of Action | NA |
| Target | NA |
| Combination Therapy | Inhibit cell wall biosynthesis |
| Other activities | NA |
| PMID | NA |
| Year of Publication | NA |
Tertiary Structure
(Technique) | Not Predicted), |
| Primary information |
|---|
| ID | antitb_1672, |
| Name | 17617692 |
| N-Terminal modification | Lariatin A |
| C-Terminal Modification | GSQLVYRWVGHSNVIKGP |
| Chemical Modification | Free |
| Linear/Cyclic | Free |
| Length | Alpha carbon of glutamine form amide bond with first glycine and gamma carbon of glutamine involved in side chain formation |
| Chirality | Cyclic |
| Nature | 18 |
| Source | D |
| Origin | Cationic |
| Species | Natural |
| Strain | Rhodococcus jostii B0171 |
| Inhibition Concentration | Mycobacterium smegmatis |
| In Vitro/ In vivo | Mycobacterium smegmatis ATCC607 |
| Cell Line | MIC = 10 μg/ml |
| Inhibition Concentration | in vitro |
| Sequence | 2007 |
| Cytotoxicity | NA |
| In vivo Model | NA |
| Lethal Dose | NA |
| Immune Responce | NA |
| Mechanism of Action | NA |
| Target | NA |
| Combination Therapy | NA |
| Other activities | NA |
| PMID | NA |
| Year of Publication | NA |
Tertiary Structure
(Technique) | Not Predicted), |
| Primary information |
|---|
| ID | antitb_1673, |
| Name | 17617692 |
| N-Terminal modification | Lariatin B |
| C-Terminal Modification | GSQLVYRWVGHSNVIKGP |
| Chemical Modification | Free |
| Linear/Cyclic | Free |
| Length | Alpha carbon of glutamine form amide bond with first glycine and gamma carbon of glutamine involved in side chain formation |
| Chirality | Cyclic |
| Nature | 18 |
| Origin | Cationic |
| Species | Natural |
| Strain | Rhodococcus jostii B0171 |
| Inhibition Concentration | Mycobacterium smegmatis |
| In Vitro/ In vivo | Mycobacterium smegmatis ATCC607 |
| Cell Line | MIC = 10 μg/ml |
| Inhibition Concentration | in vitro |
| Sequence | 2007 |
| Cytotoxicity | NA |
| In vivo Model | NA |
| Lethal Dose | NA |
| Immune Responce | NA |
| Mechanism of Action | NA |
| Target | NA |
| Combination Therapy | NA |
| Other activities | NA |
| PMID | NA |
| Year of Publication | NA |
Tertiary Structure
(Technique) | Not Predicted), |